Home
Clint Login
Become A Client: Register Now
(Clinic (or) Hospital (or) Doctor (or) Collection Center)
S.No | Test_Code | Test Type | Method | Description | Sample | Schedule | TAT |
---|---|---|---|---|---|---|---|
S.No | Test_Code | Test Type | Method | Description | Sample | Schedule | TAT |
1 | BGPCR899 | Molecular | MICROARRY | CHROMOSOMAL MICROARRAY | Whole Blood in K2 - EDTA | WEEKLY | 9 DAYS |
2 | BGPCR898 | Molecular | Real Time PCR | COVID-19 RT PCR TATA OMISURE | Oro / Naso pharyngeal swab in VTM | DAILY | 1 Day |
3 | BGPCR897 | Molecular | Real Time PCR | BRUCELLA DNA PCR QUALITATIVE | SERUM, BODY FLUIDS | DAILY | 3 DAYS |
4 | BGPCR896 | Molecular | Real Time PCR | LEPTOSPIRA QUALITATIVE PCR Assay | Plasma, Serum, Body fluids | DAILY | 72 HRS |
5 | BGPCR895 | Molecular | Real Time PCR | COVID -19 ( 2019 nCOV) QUAL rt PCR Confirmatory Test - N, E & RdRP genes | Oro / Naso pharyngeal swab in VTM | DAILY | 1 DAY |
6 | BGPCR 894 | Molecular | real time PCR | H1N1 SWINE FLU PCR QUALITATIVE | NASAL SWAB | DAILY | 4 DAYS |
7 | BGPCR893 | Molecular | SEQUENCING | C KIT MUTATIONS - EXONS 9,11, 13, 17 | WB EDTA | DAILY | 5 DAYS |
8 | BGPCR892 | Molecular | Real TIme PCR | HSV (Herpes Simplex Virus) 1 & 2 QUANT PCR | CSF, Plasma, Serum, Body Fluids | DAILY | 3 DAYS |
9 | BGPCR891 | Molecular | Real Time PCR | DENGUE VIRUS RNA PCR | Serum, Body Fluid | DAIL | 4 DAYS |
10 | BGPCR890 | Molecular | Real Time PCR | TORCH PCR PANEL - Toxoplasma, Rubella, CMV, HSV 1 & 2 | WB EDTA, Serum, Bldy Fluid | DAILY | 4 DAYS |
11 | BGPCR889 | Molecular | Real Time PCR | CHIKUNGUNYA VIRUS RNA PCR QUALITATIVE | Serum 2mL, Body Fluids | DAILY | 3 DAYS |
12 | BGPCR888 | Molecular | PCR | AML PCR - AML1 / ETO - t(8;21)(q22;q22) | WB/BM in K2 EDTA | DAILY | 3 DAYS |
13 | BGPCR887 | Molecular | PCR | AML PCR - INVERSION 16 (p13;q22) CBF? (16q22) and MYH11 (16p13) | WB/BM in K2 EDTA | DAILY | 3 DAYS |
14 | BGPCR886 | Molecular | PCR & SEQUENCING | Delta 32 (CCR5 GENE ) MUTATIONS | WB EDTA | DAILY | 7 days |
15 | BGPCR885 | Molecular | PCR & SEQUENCING | HFE GENE MUTATIONS (3) - HEREDITARY HEMOCHROMATOSIS | WB-EDTA 3mL | DAILY | 7 DAYS |
16 | BGPCR884 | Molecular | Real Time PCR | VIRAL MENINGOENCEPHALITIS PANEL (CMV, HSV, EBV, VZV) in CSF by PCR | CSF | DAILY | 6 DAYS |
17 | BGPCR883 | Molecular | Real Time PCR | NAT PCR - HIV 1 & 2, HCV and HBV | Plasma EDTA / Serum - 2mL | DAILY | 48 HRS |
18 | BGPCR 882 | Molecular | PCR & SEQUENCING | AML PCR PANEL II - FLT3, MPM1 & C/EBPA ( WITH NORMA CYTOGENETICS) | WB / BM in K3-EDTA 4mL | DAILY | 7 DAYS |
19 | BGPCR881 | Molecular | RT-PCR & SEQUENCING | MPN REFLEX PANEL BCR-ABL qual, JAK2V617F, JAK2 EXON 12, CAL-R, MPL MUTATIONS | WB EDTA | DAILY | 9 DAYS |
20 | BGPCR 880 | Molecular | Real Time PCR | MTB ( M tuberulosis) & NTM (Non Tuberculosis Microorganisms) PCR | 2 - 3 ml Sputum, CSF, Body fluids | DAILY | 2 DAYS |
21 | BGPCR879 | Molecular | Real Time PCR | STD - 8 Pathogens Detection - Chlamydia, Neisseria, Ureaplasma, Mycoplasma genitalium, Mycoplasma hominis, Trichomonas, | 2 - 5 ml – Serum, Body fluids, Urine | DAILY | 4 DAYS |
22 | BGPCR878 | Molecular | PCR | PDGFR ALPHA GENE MUTATIONS | WB / BM in EDTA | DAILY | 4 DAYS |
23 | BGPCR877 | Molecular | real time PCR | HIV 2 RNA Real Time PCR Qualitative | WB EDTA | DAILY | 3 DAYS |
24 | BGPCR876 | Molecular | PCR + SEQUENCING | TACROLIMUS GENOTYPING CYP3A5 ASSAY | WB EDTA | DAILY | 5 DAYS |
25 | BGPCR875 | Molecular | Real time PCR | HIV 2 RNA QUANTITATIVE (Viral Load) PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
26 | BGPCR874 | Molecular | PCR | Y Chromosome Micro Deletion (16 Mutations) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
27 | BGPCR873 | Molecular | PCR | Varicella Zoster Virus (VZV) detection | 2 – 3 mL blood or body fluids | Daily | 3DAYS |
28 | BGPCR872 | Molecular | PCR + SEQUEN | UGT1A1 (GILBERT’S SYNDROME) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
29 | BGPCR871 | Molecular | PCR + SEQUEN | TPMT (Thio Purine Methyl Transferase) genotyping | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
30 | BGPCR870 | Molecular | PCR | TOXOPLASMA – Qualitative DNA PCR | 2 - 3 ml – serum, Body fluids | Daily | 3 DAYS |
31 | BGPCR869 | Molecular | Real Time PCR | THROMBOPHILIA PCR PROFILE – Factor II (Prothrombin Gene Mutation, FACTOR V | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
32 | BGPCR868 | Molecular | PCR | Spinal Muscular Atrophy (SMN1) Gene Analysis | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
33 | BGPCR867 | Molecular | PCR | SCA (Spino Cerebral ataxia) Panel (1, 2, 3, 6, 7, 10 & 12) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
34 | BGPCR866 | Molecular | PCR | Sickle Cell Anaemia | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
35 | BGPCR865 | Molecular | PCR | Rubella Virus – Qualitative RNA PCR | 2 - 3 ml – SERUM/CSF/WB EDTA | Daily | 3DAYS |
36 | BGPCR864 | Molecular | Real time PCR | PML/RARa (AML - M3) (APML) – Quantitative PCR | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
37 | BGPCR863 | Molecular | Real time PCR | PML/RARa (AML - M3) (APML) – Qualitative PCR | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
38 | BGPCR862 | Molecular | PCR | PARVO VIRUS B19 DNA – Qualitative PCR | 2 - 3 ml – serum, Body fluids | Daily | 3DAYS |
39 | BGPCR861 | Molecular | Sequencing | Non Invasive Prenatal Testing (NIPT) | 4 - 5 ml – Maternal Blood | Daily | 21 DAYS |
40 | BGPCR860 | Molecular | PCR | NPM1 ( Nucleophosmin -1) gene mutation Assay | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
41 | BGPCR859 | Molecular | Real time PCR | MTB (M tuberculosis) Qualitative real time PCR | 2 - 3 ml Sputum, CSF, Body fluids | Daily | 3 DAYS |
42 | BGPCR858 | Molecular | PCR + SEQUEN | MPL – Myelo Proliferative Leukemia Assay | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
43 | BGPCR857 | Molecular | Real time PCR | MTHFR - Gene Mutation (Homocysteinemia) Assay | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
44 | BGPCR856 | Molecular | PCR + SEQUEN | KRAS (Colorectal Cancer Marker) MUTATIONS | Paraffin Tissue Block | Daily | 7 DAYS |
45 | BGPCR855 | Molecular | PCR + SEQUEN | JAK2 mutation panel (Exon 12 – 15) | 2 - 3 ml – PB in EDTA | Daily | 7 DAYS |
46 | BGPCR854 | Molecular | Real time PCR | JAK2 (Janus Kinase 2) V617F for MPDs | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
47 | BGPCR853 | Molecular | PCR + SEQUEN | Inter leukin 28B (IL28B) Polymorphism | 2 - 3 ml – PB in EDTA | Daily | 7 DAYS |
48 | BGPCR852 | Molecular | PCR + SEQUEN | IRMA (Imatinib Resistance Mutation Assay) | 2 - 3 ml – PB in EDTA | Daily | 7 DAYS |
49 | BGPCR851 | Molecular | Real time PCR | HPV - Human Papiloma Virus 16, 18 & High Risk Genotyping | EMB / body fluids / cervical swab | Daily | 3 DAYS |
50 | BGPCR850 | Molecular | PCR + SEQUEN | HIV -1 DRUG RESISTANCE ASSAY (PI, NRTI, NNRTI) | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 21 DAYS |
51 | BGPCR849 | Molecular | Real time PCR | HIV1 MONITORING ( Viral Load & CD4/CD8) | 2 - 3 ml – Serum / Plasma & PB in EDTA | Daily | 3 DAYS |
52 | BGPCR848 | Molecular | Real time PCR | HIV 1 RNA QUANTITATIVE (Viral Load) PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
53 | BGPCR847 | Molecular | Real time PCR | HIV 1 RNA Qualitative (Detection) PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
54 | BGPCR846 | Molecular | Real time PCR | HIV1 Proviral DNA Qualitative PCR | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
55 | BGPCR845 | Molecular | Real time PCR | HSV (Herpes Simplex Virus) 1 & 2 Qual PCR | 2 - 3 ml – PB in EDTA / CSF / Fluids | Daily | 3 DAYS |
56 | BGPCR844 | Molecular | PCR | HLA typing – A, B, C, DQ, DR ( BMT) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
57 | BGPCR843 | Molecular | PCR | HLA typing – A, B, DR ( NEPHRO) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
58 | BGPCR842 | Molecular | PCR | HLA typing – DR & DQB1 (Class II) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
59 | BGPCR841 | Molecular | PCR | HLA typing – DR (Class II) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
60 | BGPCR840 | Molecular | PCR | HLA typing – ABC (Class I) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
61 | BGPCR839 | Molecular | PCR | HLA typing – AB (Class I) | 2 - 3 ml – PB in EDTA | Daily | 5 DAYS |
62 | BGPCR838 | Molecular | Real time PCR | HLA B5701 PCR ASSAY (Abacavir Hypersensitivity) | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
63 | BGPCR837 | Molecular | Real time PCR | HLA B27 Qualitative PCR ASSAY | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
64 | BGPCR836 | Molecular | PCR + SEQUEN | Hepatitis C Virus (HCV) – Genotyping | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 5 DAYS |
65 | BGPCR835 | Molecular | Real time PCR | Hepatitis C Virus (HCV) RNA – Quantitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
66 | BGPCR834 | Molecular | Real time PCR | Hepatitis C Virus (HCV) RNA– Qualitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
67 | BGPCR833 | Molecular | PCR + SEQUEN | Hepatitis B Virus (HBV) Drug Resistance Studies | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 7 DAYS |
68 | BGPCR832 | Molecular | PCR + SEQUEN | Hepatitis B Virus (HBV) – Genotyping | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 5 DAYS |
69 | BGPCR831 | Molecular | Real time PCR | Hepatitis B Virus (HBV) DNA – Quantitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
70 | BGPCR830 | Molecular | Real time PCR | Hepatitis B Virus (HBV) DNA– Qualitative PCR | 2 - 3 ml – Serum / PB or Plasma in EDTA | Daily | 3 DAYS |
71 | BGPCR829 | Molecular | Real time PCR | Helicobacter Pylori – Qualitative PCR | 2 - 3 ml – SERUM / Blood / FECUS | Daily | 3 DAYS |
72 | BGPCR828 | Molecular | PCR | GENEXPERT MTB with rifampicin resistance, qualitative | 2 - 3 ml Sputum / BAL / CSF /Body fluids | Daily | 3 DAYS |
73 | BGPCR827 | Molecular | PCR | FRAGILE X SYNDROME ( FMR1 GENE) | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
74 | BGPCR826 | Molecular | PCR + RFLP | FLT3 (fms like tyrosine kinase 3) Gene Mutation Assay | 2 - 3 ml – WB / BM in Sodium EDTA | Daily | 3 DAYS |
75 | BGPCR825 | Molecular | real time PCR | 5 - FLUORO URACIL Assay | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
76 | BGPCR824 | Molecular | real time PCR | FACTOR V LEIDEN Mutation Assay | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
77 | BGPCR823 | Molecular | PCR | FACTOR II (PROTHROMBIN) Mutation Assay | 2 - 3 ml – PB in EDTA | Daily | 3 DAYS |
78 | BGPCR822 | Molecular | Real time PCR | Epstein Barr Virus (EBV) Qualitative PCR Assay | 2 - 3 ml – Serum, body fluids | Daily | 3 DAYS |
79 | BGPCR821 | Molecular | PCR + SEQUEN | EGFR Mutation Study (10 Mutations) | 2 - 3 ml – PB in EDTA | Daily | 6 DAYS |
80 | BGPCR820 | Molecular | PCR + SEQUEN | DPD Gene Mutations (5-FU toxicity) detection | 2 - 3 ml – PB in EDTA | Daily | 6 DAYS |
81 | BGPCR819 | Molecular | PCR | DUCHNE MUSCULAR DYSTROPHY (DMD) (26 exons) | 2 - 3 ml – PB in EDTA | Daily | 6 DAYS |
82 | BGPCR818 | Molecular | PCR | CYSTIC FIBROSIS (? F508, G551D/R553X, G542X) | 2 - 3 ml – PB in EDTA | Daily | 6 DAYS |
83 | BGPCR817 | Molecular | Real time PCR | CYTOMEGALO VIRUS (CMV) – Quantitative PCR | 2 - 3 ml – PB in EDTA / body fluids | Daily | 3DAYS |
84 | BGPCR816 | Molecular | Real time PCR | CYTOMEGALO VIRUS (CMV) – Qualitative PCR | 2 - 3 ml – PB in EDTA / body fluids | Daily | 3DAYS |
85 | BGPCR815 | Molecular | PCR | Chlamydia trachomatis – Qualitative PCR | Genital/Urethral swab/ body fluids | Daily | 3DAYS |
86 | BGPCR814 | Molecular | PCR | CEBPA (CCAAT/Enhancer Binding Protein ?) mutations | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
87 | BGPCR813 | Molecular | PCR + Sequencing | Calreticulin (CAL R) gene mutations | 2 - 3 ml – WB in K2 EDTA | Daily | 3DAYS |
88 | BGPCR812 | Molecular | PCR + Sequencing | BRACA 1 & BRACA 2 | 4 - 6 ml – WB in K2 EDTA | Daily | 28 days |
89 | BGPCR811 | Molecular | Real time PCR | BRAF Mutation (Proto-Oncogene) | Paraffin Embedded Tissue Block | Daily | 3DAYS |
90 | BGPCR810 | Molecular | Real time PCR | BK VIRUS (BK Poliyomavirus) JC / BK Virus PCR | 2 - 3 ml – Serum/ PB in K2 EDTA | Daily | 3DAYS |
91 | BGPCR809 | Molecular | Real time PCR | BCR/ABL (ALL) Minor (p190) Qualitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
92 | BGPCR808 | Molecular | Real time PCR | BCR/ABL (CML) Major (p210) Quantitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
93 | BGPCR807 | Molecular | Real time PCR | BCR/ABL (CML) Major (p210) Qualitative | 2 - 3 ml – WB/BM in K2 EDTA | Daily | 3DAYS |
94 | BGPCR806 | Molecular | PCR | Beta THALASSEMIA Mutations | 2 - 3 ml – WB in K2 EDTA | Daily | 6 DAYS |
95 | BGPCR805 | Molecular | Real time PCR | Adenovirus DNA PCR Qualitative PCR assay | 2 - 3 ml – WB in K2 EDTA | Daily | 3DAYS |
96 | BGPCR804 | Molecular | BACTEC + LPA | ACID FAST SUCEPTIBILITY - 2nd line drugs - Fluoroquinol | Mycobacterium Culture | Daily | 6 DAYS |
97 | BGPCR803 | Molecular | BACTEC + LPA | ACID FAST SUCEPTIBILITY - 1st line drugs - Rifampicin & Isoniazid | Mycobacterium Culture | Daily | 6 DAYS |
98 | BGPCR802 | Molecular | PCR | AML PCR PANEL - AML1(21q22) and ETO(8q22), INV 16 (p13;q22), PML (15q22) and RARa(17q21) - t(15;17) (q21;q22), MLL | 2 - 3 ml – WB / BM in K2 EDTA | Daily | 6 DAYS |
99 | BGPCR801 | Molecular | PCR | ALL PCR PANEL - BCR / ABL - t (9;22)(q34;q11) E2A/ PBX1 - t(1;19) MLL1 / AF4 - t(4;11), TEL / AML1 - t(12;21) | 2 - 3 ml – WB / BM in K2 EDTA | Daily | 6 DAYS |